RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model
Authors
Keywords
-
Journal
PROSTATE
Volume 68, Issue 8, Pages 820-829
Publisher
Wiley
Online
2008-03-07
DOI
10.1002/pros.20744

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.